This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

South Korean AI startup claims big step closer to scientific superintelligence

By Choonsik Yoo ( August 28, 2025, 07:46 GMT | Insight) -- Asteromorph, a six-month-old South Korean artificial intelligence startup, announced that it has developed a model capable of autonomously discovering new scientific concepts without human intervention. The company said its model generates novel ideas through a decontextualization process and has already produced a concrete experimental plan for suppressing liver cancer cell proliferation. Asteromorph aims to launch a website to systematize AI-discovered concepts, with free academic access but licensing requirements for commercialization.A six-month-old South Korean artificial intelligence startup claimed today that it has developed a new model capable of autonomously discovering new scientific concepts without human intervention, a move its founder described as a significant step toward superintelligence in scientific research....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections